Jennifer Kim

Stock Analyst at Cantor Fitzgerald

(3.49)
# 925
Out of 4,996 analysts
35
Total ratings
57.14%
Success rate
19.7%
Average return

Stocks Rated by Jennifer Kim

Belite Bio
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $69.98
Upside: -
Precigen
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $3.51
Upside: -
Insmed
Feb 20, 2025
Reiterates: Overweight
Price Target: n/a
Current: $137.03
Upside: -
Fortress Biotech
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $3.91
Upside: -
EyePoint Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $13.90
Upside: -
Ocugen
Aug 31, 2023
Maintains: Overweight
Price Target: $2.5$2
Current: $1.46
Upside: +36.99%
Lipocine
Jul 27, 2023
Reiterates: Overweight
Price Target: $33
Current: $2.73
Upside: +1,108.79%
ProQR Therapeutics
May 17, 2023
Maintains: Overweight
Price Target: $5$4.5
Current: $2.11
Upside: +113.27%
Aytu BioPharma
May 17, 2022
Maintains: Overweight
Price Target: $220$100
Current: $1.74
Upside: +5,647.13%